Eton Pharmaceuticals (ETON) Other financing activities (2019 - 2025)
Eton Pharmaceuticals (ETON) posted Other financing activities of $204000.0 for Q4 2025, down 48.22% sequentially from $394000.0 in Q1 2025, and down 79.9% YoY from $1.0 million in Q4 2024.
Eton Pharmaceuticals (ETON) Other financing activities (2019 - 2025) Analysis & Trends
Eton Pharmaceuticals has reported Other financing activities for 7 years, with the latest figure at $204000.0 in Q4 2025.
- Quarterly Other financing activities fell 79.9% year-over-year to $204000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $598000.0 (down 49.79% YoY) and the FY2025 annual result came in at $598000.0, down 49.79% from the prior year.
- Other financing activities declined to $204000.0 in Q4 2025 per ETON's latest filing, from $394000.0 in the prior quarter.
- Over five years, Other financing activities peaked at $1.0 million in Q4 2024 and troughed at -$117000.0 in Q4 2022.
- A 5-year average of $162125.0 and a median of $110000.0 in 2021 frame the typical range for Other financing activities.
- The sharpest annual moves came in 2022 and 2025: Other financing activities slumped 272.06% in 2022, then surged 5528.57% in 2025.
- Over 5 years, Other financing activities stood at $68000.0 in 2021, then plunged by 272.06% to -$117000.0 in 2022, then soared by 49.57% to -$59000.0 in 2023, then surged by 1820.34% to $1.0 million in 2024, then slumped by 79.9% to $204000.0 in 2025.
- According to Business Quant data, Other financing activities over the past three periods registered $204000.0, $394000.0, and $1.0 million for Q4 2025, Q1 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Eton Pharmaceuticals | 1.65 Bn | 1.62 Bn | 25.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 204,000.00 |
| Dec 31, 2025 | 204,000.00 |
| Mar 31, 2025 | 394,000.00 |
| Mar 31, 2025 | 394,000.00 |
| Dec 31, 2024 | 1.02 Mn |
| Dec 31, 2024 | 1.02 Mn |
| Jun 30, 2024 | 169,000.00 |
| Jun 30, 2024 | 169,000.00 |
| Mar 31, 2024 | 7,000.00 |
| Mar 31, 2024 | 7,000.00 |
| Dec 31, 2023 | -59,000.00 |
| Dec 31, 2023 | -59,000.00 |
| Sep 30, 2023 | 17,000.00 |
| Sep 30, 2023 | 17,000.00 |
| Jun 30, 2023 | 139,000.00 |
| Jun 30, 2023 | 139,000.00 |
| Mar 31, 2023 | 132,000.00 |
| Mar 31, 2023 | 132,000.00 |
| Dec 31, 2022 | -117,000.00 |
| Dec 31, 2022 | -117,000.00 |